- Home
- NUVB vs HSTM Comparison
NUVB vs HSTM Comparison
Compare NUVB & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- HSTM
- Stock Information
- Founded
- NUVB 2018
- HSTM 1990
- Country
- NUVB United States
- HSTM United States
- Employees
- NUVB N/A
- HSTM N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- HSTM Computer Software: Programming Data Processing
- Sector
- NUVB Health Care
- HSTM Technology
- Exchange
- NUVB Nasdaq
- HSTM Nasdaq
- Market Cap
- NUVB 837.0M
- HSTM 828.5M
- IPO Year
- NUVB N/A
- HSTM 2000
- Fundamental
- Price
- NUVB $2.75
- HSTM $26.49
- Analyst Decision
- NUVB Strong Buy
- HSTM Hold
- Analyst Count
- NUVB 6
- HSTM 2
- Target Price
- NUVB $8.00
- HSTM $28.00
- AVG Volume (30 Days)
- NUVB 4.6M
- HSTM 187.8K
- Earning Date
- NUVB 08-07-2025
- HSTM 08-04-2025
- Dividend Yield
- NUVB N/A
- HSTM 0.47%
- EPS Growth
- NUVB N/A
- HSTM 14.03
- EPS
- NUVB N/A
- HSTM 0.67
- Revenue
- NUVB $14,355,000.00
- HSTM $295,211,000.00
- Revenue This Year
- NUVB $98.78
- HSTM $5.00
- Revenue Next Year
- NUVB $489.71
- HSTM $5.20
- P/E Ratio
- NUVB N/A
- HSTM $39.60
- Revenue Growth
- NUVB 900.35
- HSTM 3.50
- 52 Week Low
- NUVB $1.54
- HSTM $25.36
- 52 Week High
- NUVB $3.46
- HSTM $34.24
- Technical
- Relative Strength Index (RSI)
- NUVB 67.35
- HSTM 49.53
- Support Level
- NUVB $2.18
- HSTM $25.91
- Resistance Level
- NUVB $2.55
- HSTM $26.83
- Average True Range (ATR)
- NUVB 0.18
- HSTM 0.57
- MACD
- NUVB 0.03
- HSTM 0.08
- Stochastic Oscillator
- NUVB 82.48
- HSTM 68.90
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.